The study found that PgLPS transgenic mice induce AD phenotypes, including increased expression of pro-inflammatory factors, Tau hyperphosphorylation (Jiang M. et al., 2021), enhanced microglia-mediated neuroinflammation, and intracellular Aβ accumulation in neurons (Wu et al., 2017). This evidence concerns the gene MAPT and Alzheimer disease.